Clinical Trial Update: Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of an anti-PD-1 antibody given alone or with Decitabine and chemotherapy for relapsed or refractory cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Anti-PD-1 antibody
• Decitabine (Decitabine)

Snippet

Sponsor: Han weidong | Conditions: Malignancies Multiple | Phase 1, Phase 2 | Status: RECRUITING